Spex

EQS-News: ABOUT YOU Holding SE: A Successful Financial Year: ABOUT YOU Grows, Delivers Positive Free Cash Flow, and Reaches Adjusted EBITDA Break-Even

Retrieved on: 
Freitag, Mai 10, 2024
USP, Investment, Acceleration, Weather, Tech, Publication, Sport, YOU, FY, Annual report, EUR, Celebrity, Gen, Entrepreneurship, Intelligence, DACH, ESG, Commerce, Roe, CASH, Marketing, Spex, Growth, TME, Retail

ABOUT YOU Holding SE: A Successful Financial Year: ABOUT YOU Grows, Delivers Positive Free Cash Flow, and Reaches Adjusted EBITDA Break-Even

Key Points: 
  • ABOUT YOU Holding SE: A Successful Financial Year: ABOUT YOU Grows, Delivers Positive Free Cash Flow, and Reaches Adjusted EBITDA Break-Even
    The issuer is solely responsible for the content of this announcement.
  • "In FY 2023/2024, we entered positive territory in terms of adjusted EBITDA, while at the same time generating growth, being free cash flow positive and gaining significant market share.
  • We are not just waiting for a faster shift from offline to online retail and brighter market conditions.
  • The ABOUT YOU Group significantly improved its margin across all cost lines and segments in FY 2023/2024.

EQS-News: Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth

Retrieved on: 
Mittwoch, April 10, 2024
Spex, AOV, Growth, AI, Overalls, Video game

Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth

Key Points: 
  • Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth
    The issuer is solely responsible for the content of this announcement.
  • Mister Spex meets 2023 guidance, gains market share again and embarks on the next chapter of sustainable growth
    Adjusted EBITDA reached € 0.9 million, an improvement of approx.
  • The core market, Germany, has been the key driver behind the strong revenue growth in 2023.
  • Dirk Graber, CEO of Mister Spex SE says: “Mister Spex had a successful year in 2023 by growing market share and adjusted EBITDA despite challenging market conditions.

EQS-News: Challenging market, strong results: Mister Spex confirms guidance with 6% revenue growth and positive adjusted EBITDA

Retrieved on: 
Montag, Februar 5, 2024
Growth, MRX, LFL, Communication, Spex, AOV, Pharmaceutical industry

This growth is within the projected guidance range of mid-high single-digit growth.

Key Points: 
  • This growth is within the projected guidance range of mid-high single-digit growth.
  • The adjusted EBITDA is expected to be in line with the guidance range, reflecting a positive adjusted EBITDA margin in the low single-digit percentage.
  • In the fourth quarter, revenue increased by 7% year-on-year, driven by a robust 10% growth in the Germany segment.
  • Mister Spex sustained its momentum in growth by further enhancing the Average Order Value (AOV), achieving a strong 10% increase.

EQS-News: Mister Spex continues to outgrow the market and to improve its profitability in Q3 – guidance for 2023 confirmed

Retrieved on: 
Donnerstag, Dezember 14, 2023
FY, Contact, Weather, MRX, Environment, Spex, EBITDA, SE, Growth, Pharmaceutical industry, Retail

In the third quarter of 2023, Mister Spex SE recorded a revenue growth of +2%, once again outperforming the market in a challenging environment.

Key Points: 
  • In the third quarter of 2023, Mister Spex SE recorded a revenue growth of +2%, once again outperforming the market in a challenging environment.
  • The quarter has been impacted by a number of external headwinds, such as reduced consumer sentiment and unseasonal weather patterns.
  • This has overshadowed the positive developments in the key categories where Mister Spex focuses on, namely prescription glasses and sunglasses.
  • Mirko Caspar, Co-CEO of Mister Spex SE: “We attach great importance to high-quality brands in the luxury and independent segment.

EQS-News: Mister Spex announces robust H1 2023 performance with 8% revenue growth, a 293 basis points gross margin improvement and the return to a positive adjusted EBITDA

Retrieved on: 
Donnerstag, August 31, 2023
Yoy, H1, Growth, Spex, EBITDA, Face, Marketing, MRX, Beauty salon, Pharmaceutical industry, Video game, Retail, Cryptocurrency

Mister Spex announces robust H1 2023 performance with 8% revenue growth, a 293 basis points gross margin improvement and the return to a positive adjusted EBITDA

Key Points: 
  • Mister Spex announces robust H1 2023 performance with 8% revenue growth, a 293 basis points gross margin improvement and the return to a positive adjusted EBITDA
    The issuer is solely responsible for the content of this announcement.
  • This revenue surge was assisted by the opening of six new stores in 2023, extending the company’s retail footprint to 74 outlets.
  • The physical retail network achieved an 11% like-for-like growth [a] in H1 2023 compared to the same period last year.
  • Management expects revenue growth in the mid to high single-digit percentage range and a positive adjusted EBITDA margin in the low single-digit percentage range.

EQS-News: Mister Spex reports strong revenue growth of 6% -   gross margin up 440 basis points in the first quarter of 2023

Retrieved on: 
Donnerstag, Mai 11, 2023
Contact, International, Marketing, MRX, Nordic, Motion, EBITDA, Growth, Weather, Spex, Environment, Pharmaceutical industry, Video game

The notable development of 19% in prescription glasses sales largely drove the growth, a testament to the company's resilient omnichannel model.

Key Points: 
  • The notable development of 19% in prescription glasses sales largely drove the growth, a testament to the company's resilient omnichannel model.
  • Despite negative consumer sentiment in the first quarter of 2023, the materialization of pent-up demand and other factors supported the development.
  • The improvement was primarily driven by higher gross margin, which reached 53.6% in the quarter up 440 basis points versus prior year (Q1 2022: 49.2%).
  • The quarterly report and further information for analysts and investors are available on the Mister Spex Investor Relations website .

EQS-News: Mister Spex delivers strong preliminary result of 8% revenue growth in 2022 in a continuously very challenging consumer market

Retrieved on: 
Donnerstag, Februar 2, 2023
Stagnation, Spex, Growth, MRX, Environment, EBITDA, ZVA, COVID-19, Optometry

Revenue increase to 210 million euros (2021: 194 million euros)

Key Points: 
  • Revenue increase to 210 million euros (2021: 194 million euros)
    According to preliminary and unaudited figures, Mister Spex SE (MRX) grew by 8% in 2022, finishing the year with 210 million euros revenue (2021: 194 million euros).
  • This corresponds to growth within the guidance range (7% to 12% growth).
  • In a continuously challenging environment, the omnichannel business model has proven to be once again advantageous and led to strong growth and market share gains.
  • With a revenue of 153 million euros (2021: 138 million euros), Mister Spex was able to strongly expand its activities in its core market in Germany.

DGAP-News: Mister Spex SE: Mister Spex Mister Spex continues to grow in the first half year

Retrieved on: 
Mittwoch, September 7, 2022
EBITDA, Spex, Lean, Acceleration, Face, Growth, MRX, Lens (anatomy), COVID, Video game, Renewable energy

Mister Spex SE (MRX), Europes leading digitally-driven omnichannel optician, continued its growth in the first half of 2022.

Key Points: 
  • Mister Spex SE (MRX), Europes leading digitally-driven omnichannel optician, continued its growth in the first half of 2022.
  • Mirko Caspar, Co-CEO Mister Spex SE, explains: Our existing Mister Spex stores showed significant double-digit growth on a like-for-like basis.
  • Dirk Graber, founder and Co-CEO Mister Spex SE, adds: Mister Spex remains very well positioned to take further market share in challenging conditions.
  • The half-year report and the presentation of the results for analysts and investors are available on the Mister Spex Investor Relations website .

DGAP-News: Mister Spex SE: CFO Sebastian Dehnen leaves Mister Spex

Retrieved on: 
Mittwoch, Juni 15, 2022
Time, Spex, IPO, Saskatchewan River Sturgeon Management Board, Technology, Security (finance), Online shopping

"Sebastian has contributed significantly to the successful IPO of Mister Spex and prepared the company for the requirements of the capital market.

Key Points: 
  • "Sebastian has contributed significantly to the successful IPO of Mister Spex and prepared the company for the requirements of the capital market.
  • Sebastian Dehnen: "My time at Mister Spex has been marked by many exciting and successful events over the past years.
  • I will of course continue to follow the successful development of Mister Spex and remain a loyal customer."
  • Founded in 2007, Mister Spex SE (together with its subsidiaries, "Mister Spex") is a multi-award-winning company that has become the leading digitally-driven omni-channel optician in Europe.

Syed Jafry Joins Antylia Scientific Board of Directors

Retrieved on: 
Montag, April 25, 2022
Percussion section, Board, EMEA, General Electric, Zimmer Biomet, Water, Executive, Research, Plastic, Life, Science, Board of directors, Cole-Parmer, CAGR, Army Science Board, Goal, GM, GE, Growth, SVP, Thermo Fisher Scientific, Director, TMO, Solution, SRL Diagnostics, Industry, GTCR, Emerging market, Fine chemical, Management, Elective surgery, Spex, Asia-Pacific

VERNON HILLS, Ill., April 25, 2022 /PRNewswire/ -- Antylia Scientific, a global leader of Molecular Diagnostic Reagents and Specialty Chemicals, Water and Air Quality Testing Equipment and Consumables, and Laboratory Products for the pharma, healthcare and environmental markets, announced today that Syed Jafry has joined its Board of Directors. Antylia is a portfolio company of GTCR, a leading private equity firm.

Key Points: 
  • VERNON HILLS, Ill., April 25, 2022 /PRNewswire/ --Antylia Scientific, a global leader of Molecular Diagnostic Reagents and Specialty Chemicals, Water and Air Quality Testing Equipment and Consumables, and Laboratory Products for the pharma, healthcare and environmental markets, announced today that Syed Jafry has joined its Board of Directors.
  • Mr. Jafry also serves on the Board of Directors of Zimmer Biomet, a global leader in orthopedics.
  • "We are excited and honored to have Syed join our Board of Directors," said Bernd Brust, Antylia's Executive Chairman of the Board.
  • Mr. Jafry commented: "I am truly honored to join the Board of Antylia Scientific and to partner with the GTCR team.